BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34091868)

  • 1. Hypofractionated whole breast irradiation after IORT treatment is safe in patients receiving adjuvant chemotherapy.
    Burgos-Burgos J; Vega V; Macias-Verde D; Gómez V; Travieso-Aja M; Travieso J; Vicente E; Murias C; Santana C; Ospina J; Lara PC
    Clin Transl Oncol; 2021 Dec; 23(12):2579-2583. PubMed ID: 34091868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated whole breast irradiation after IORT treatment: evaluation of acute toxicity and cosmesis.
    Burgos-Burgos J; Vega V; Macias-Verde D; Gómez V; Travieso-Aja M; Travieso J; Vicente E; Santana C; Ospina J; Lara PC
    Clin Transl Oncol; 2021 Jan; 23(1):179-182. PubMed ID: 32445034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
    Fastner G; Reitsamer R; Urbański B; Kopp P; Murawa D; Adamczyk B; Karzcewska A; Milecki P; Hager E; Reiland J; Ciabattoni A; Matuschek C; Budach W; Nowell K; Schumacher C; Ricke A; Fusco V; Vidali C; Alessandro M; Ivaldi GB; Ziegler I; Fussl C; Zehentmayr F; Grambozov B; Sir A; Hitzl W; Ricardi U; Sedlmayer F
    Radiother Oncol; 2020 May; 146():136-142. PubMed ID: 32151790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative irradiation in breast cancer: preliminary results in 80 patients as partial breast irradiation or anticipated boost prior to hypo-fractionated whole breast irradiation.
    Li X; Sanz J; Argudo N; Vernet-Tomas M; Rodríguez N; Torrent L; Fernández-Velilla E; Pera O; Huang Y; Nicolau P; Jiménez M; Segura M; Algara M
    Clin Transl Oncol; 2022 May; 24(5):829-835. PubMed ID: 34792725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer.
    Bhandari T; Babaran W; Forouzannia A; Williams V; Harness J; Carpenter M; Gobran M; Khanijou R; Wagman B; Ash R; Wagman LD
    Brachytherapy; 2017; 16(6):1232-1238.e2. PubMed ID: 29032999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of hypofractionated breast irradiation and intraoperative electron boost in early breast cancer: A randomized non-inferiority clinical trial.
    Fadavi P; Nafissi N; Mahdavi SR; Jafarnejadi B; Javadinia SA
    Cancer Rep (Hoboken); 2021 Oct; 4(5):e1376. PubMed ID: 33797199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical analysis of intraoperative radiotherapy during breast-conserving surgery of early breast cancer in the Chinese Han population.
    Wang X; Liu J; Wang W; Feng Q; Wang X
    Oncotarget; 2015 Dec; 6(40):43120-6. PubMed ID: 26517686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue following radiotherapy of low-risk early breast cancer - a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419).
    Forster T; Jäkel C; Akbaba S; Krug D; Krempien R; Uhl M; Häfner MF; König L; Koerber SA; Harrabi S; Bernhardt D; Behnisch R; Krisam J; Hennigs A; Sohn C; Heil J; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Jun; 15(1):134. PubMed ID: 32487184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial).
    Franceschini D; Loi M; Chiola I; Arculeo S; Marzo M; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
    Clin Breast Cancer; 2021 Jun; 21(3):231-238. PubMed ID: 33121891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.
    De Rose F; Fogliata A; Franceschini D; Iftode C; Navarria P; Comito T; Franzese C; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
    Breast; 2018 Dec; 42():31-37. PubMed ID: 30149235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
    Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
    Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cosmetic Outcome and Chronic Breast Toxicity After Intraoperative Radiation Therapy (IORT) as a Single Modality or as a Boost Using the Intrabeam
    Key S; Miglierini P; Dupré PF; Guilbert S; Lucia AS; Abgral R; Conan-Charlet V; Uguen A; Pradier O; Schick U
    Ann Surg Oncol; 2017 Sep; 24(9):2547-2555. PubMed ID: 28608120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation.
    Shah C; Ward MC; Tendulkar RD; Cherian S; Vicini F; Singer ME
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):397-402. PubMed ID: 30253236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and cosmetic outcomes after treatment with a novel form of breast IORT.
    Meneveau MO; Petroni GR; Varhegyi NE; Hulse JC; Schroen AT; Brenin DR; Janowski EM; Berger AC; Lazar MA; Simone NL; Showalter TN; Showalter SL
    Brachytherapy; 2020; 19(5):679-684. PubMed ID: 32571746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Accelerated Whole Breast Irradiation.
    Shah C; Fleming-Hall E; Asha W
    Clin Breast Cancer; 2023 Apr; 23(3):237-240. PubMed ID: 36792457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
    Yadav BS; Sharma SC; Singh G; Dahiya D
    J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.